In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.

Journal Article (Journal Article)

SOURCE CITATION: Navarese EP, Khan SU, Kolodziejczak M, et al. Comparative efficacy and safety of oral P2Y 12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials. Circulation. 2020;142:150-60. 32468837.

Full Text

Duke Authors

Cited Authors

  • Nanna, MG; Granger, CB

Published Date

  • October 20, 2020

Published In

Volume / Issue

  • 173 / 8

Start / End Page

  • JC44 -

PubMed ID

  • 33075264

Pubmed Central ID

  • 33075264

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/ACPJ202010200-044

Language

  • eng

Conference Location

  • United States